On 17 October 2019, orphan designation EU/3/19/2217 was granted by the European Commission to Recordati Rare Diseases, France, for propranolol hydrochloride for the treatment of retinopathy of prematurity.
|Disease / condition||
Treatment of retinopathy of prematurity
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see: